Valanafusp alfa (AGT-181) is a chimeric monoclonal antibody that fuses human alpha-L-iduronidase (IDUA) and targets the human insulin receptor (HIR). Valanafusp alfa has brain penetrating properties, making it useful for research on mucopolysaccharidosis type I (MPS I)[1].
Molecular Weight:
(284.23 kDa)
Purity:
98.42
CAS Number:
[1815583-32-4]
Target:
Insulin Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted